35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Inflammation of Skin
Status:
RECRUITING
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
To explore the clinical effect and safety of 35 kDa hyaluronic acid fragment ( HA35 ) combined with negative pressure microneedle technology in improving skin problems.